skip to main content
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Monoclonal Antibodies remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Intracellular trafficking of new anticancer therapeutics: antibody-drug conjugates
Material Type:
Artigo
Adicionar ao Meu Espaço

Intracellular trafficking of new anticancer therapeutics: antibody-drug conjugates

Kalim, Muhammad ; Chen, Jie ; Wang, Shenghao ; Lin, Caiyao ; Ullah, Saif ; Liang, Keying ; Ding, Qian ; Chen, Shuqing ; Zhan, Jinbiao

Drug design, development and therapy, 2017-01, Vol.11, p.2265-2276 [Periódico revisado por pares]

New Zealand: Dove Medical Press Limited

Texto completo disponível

2
Quantification of an Antibody-Conjugated Drug in Fat Plasma by an Affinity Capture LC-MS/MS Method for a Novel Prenyl Transferase-Mediated Site-Specific Antibody-Drug Conjugate
Material Type:
Artigo
Adicionar ao Meu Espaço

Quantification of an Antibody-Conjugated Drug in Fat Plasma by an Affinity Capture LC-MS/MS Method for a Novel Prenyl Transferase-Mediated Site-Specific Antibody-Drug Conjugate

Lee, Byeong Ill ; Park, Min-Ho ; Byeon, Jin-Ju ; Shin, Seok-Ho ; Choi, Jangmi ; Park, Yuri ; Park, Yun-Hee ; Chae, Jeiwook ; Shin, Young G

Molecules (Basel, Switzerland), 2020-03, Vol.25 (7), p.1515 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

3
Antibody–drug conjugates: Basic concepts, examples and future perspectives
Material Type:
Artigo
Adicionar ao Meu Espaço

Antibody–drug conjugates: Basic concepts, examples and future perspectives

Casi, Giulio ; Neri, Dario

Journal of controlled release, 2012-07, Vol.161 (2), p.422-428 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

4
Marine-Derived Anticancer Agents: Clinical Benefits, Innovative Mechanisms, and New Targets
Material Type:
Artigo
Adicionar ao Meu Espaço

Marine-Derived Anticancer Agents: Clinical Benefits, Innovative Mechanisms, and New Targets

Pereira, Renato B ; Evdokimov, Nikolai M ; Lefranc, Florence ; Valentão, Patrícia ; Kornienko, Alexander ; Pereira, David M ; Andrade, Paula B ; Gomes, Nelson G M

Marine drugs, 2019-06, Vol.17 (6), p.329 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

5
Antibody–drug conjugates transform the outcome of individuals with low‐HER2‐expression advanced breast cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Antibody–drug conjugates transform the outcome of individuals with low‐HER2‐expression advanced breast cancer

Qu, Fei ; Lu, Rongrong ; Liu, Qian ; Wu, Xuefang ; Huang, Xiang ; Yin, Yongmei ; Li, Wei

Cancer, 2024-04, Vol.130 (S8), p.1392-1402 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

6
Focus on monoclonal antibodies targeting B‐cell maturation antigen (BCMA) in multiple myeloma: update 2021
Material Type:
Artigo
Adicionar ao Meu Espaço

Focus on monoclonal antibodies targeting B‐cell maturation antigen (BCMA) in multiple myeloma: update 2021

Demel, Ivo ; Bago, Julio Rodriguez ; Hajek, Roman ; Jelinek, Tomas

British journal of haematology, 2021-05, Vol.193 (4), p.705-722 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

7
Recent Advances in Drug–Antibody Ratio Determination of Antibody–Drug Conjugates
Material Type:
Artigo
Adicionar ao Meu Espaço

Recent Advances in Drug–Antibody Ratio Determination of Antibody–Drug Conjugates

Matsuda, Yutaka ; Mendelsohn, Brian A.

Chemical and Pharmaceutical Bulletin, 2021/10/01, Vol.69(10), pp.976-983 [Periódico revisado por pares]

Tokyo: The Pharmaceutical Society of Japan

Texto completo disponível

8
Bystander killing effect of DS‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity
Material Type:
Artigo
Adicionar ao Meu Espaço

Bystander killing effect of DS‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity

Ogitani, Yusuke ; Hagihara, Katsunobu ; Oitate, Masataka ; Naito, Hiroyuki ; Agatsuma, Toshinori

Cancer science, 2016-07, Vol.107 (7), p.1039-1046 [Periódico revisado por pares]

England: John Wiley & Sons, Inc

Texto completo disponível

9
Antibody-targeted drugs and drug resistance—Challenges and solutions
Material Type:
Artigo
Adicionar ao Meu Espaço

Antibody-targeted drugs and drug resistance—Challenges and solutions

Shefet-Carasso, LeeRon ; Benhar, Itai

Drug resistance updates, 2015-01, Vol.18, p.36-46 [Periódico revisado por pares]

Scotland: Elsevier Ltd

Texto completo disponível

10
HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks
Material Type:
Artigo
Adicionar ao Meu Espaço

HER2-Directed Therapy in Advanced Breast Cancer: Benefits and Risks

Mandó, Pablo ; Waisberg, Federico ; Pasquinelli, Rosario ; Rivero, Sergio ; Ostinelli, Alexis ; Perazzo, Florencia

OncoTargets and therapy, 2023-01, Vol.16, p.115-132 [Periódico revisado por pares]

New Zealand: Dove Medical Press Limited

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (527)
  2. Revistas revisadas por pares (496)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (521)
  2. Book Chapters  (17)
  3. Livros  (9)
  4. Newsletter Articles  (5)
  5. Artigos de Jornal  (3)
  6. Recursos Textuais  (2)
  7. Reports  (2)
  8. magazinearticle  (2)
  9. Dissertações  (2)
  10. Verbetes  (2)
  11. Resenhas  (1)
  12. Anais de Congresso  (1)
  13. Mais opções open sub menu

Data de Publicação 

De até
  1. Antes de1992  (5)
  2. 1992Até2007  (7)
  3. 2008Até2012  (23)
  4. 2013Até2017  (95)
  5. Após 2017  (441)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (562)
  2. Japonês  (74)
  3. Chinês  (3)
  4. Polonês  (1)
  5. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.